| Symbol |
Name |
Standardized Value |
|
CALD1
|
caldesmon 1
|
3.516
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
3.266
|
|
CD34
|
CD34 molecule
|
3.174
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
3.036
|
|
MYOG
|
myogenin (myogenic factor 4)
|
2.889
|
|
TP53
|
tumor protein p53
|
2.825
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
2.747
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
2.744
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
2.736
|
|
CD99
|
CD99 molecule
|
2.713
|
|
MED12
|
mediator complex subunit 12
|
2.686
|
|
CD99L2
|
CD99 molecule-like 2
|
2.685
|
|
EWSR1
|
EWS RNA-binding protein 1
|
2.585
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
2.569
|
|
MYOD1
|
myogenic differentiation 1
|
2.558
|
|
MME
|
membrane metallo-endopeptidase
|
2.543
|
|
CDK4
|
cyclin-dependent kinase 4
|
2.518
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
2.484
|
|
PGR
|
progesterone receptor
|
2.473
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
2.468
|
|
ATRX
|
alpha thalassemia/mental retardation syndrome X-linked
|
2.454
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
2.417
|
|
ZC3H7B
|
zinc finger CCCH-type containing 7B
|
2.414
|
|
CD68
|
CD68 molecule
|
2.413
|
|
PTEN
|
phosphatase and tensin homolog
|
2.399
|
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
2.394
|
|
JAZF1
|
JAZF zinc finger 1
|
2.364
|
|
ESR1
|
estrogen receptor 1
|
2.359
|
|
SS18
|
synovial sarcoma translocation, chromosome 18
|
2.354
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
2.338
|
|
NF1
|
neurofibromin 1
|
2.336
|
|
CD274
|
CD274 molecule
|
2.326
|
|
YWHAE
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
|
2.31
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
2.288
|
|
HMGA2
|
high mobility group AT-hook 2
|
2.276
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
2.267
|
|
WT1
|
Wilms tumor 1
|
2.247
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
2.245
|
|
KRT7
|
keratin 7, type II
|
2.244
|
|
FH
|
fumarate hydratase
|
2.244
|
|
NUTM2A
|
NUT family member 2A
|
2.237
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
2.236
|
|
CALB2
|
calbindin 2
|
2.218
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
2.216
|
|
PAX3
|
paired box 3
|
2.186
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
2.182
|
|
SSX4B
|
synovial sarcoma, X breakpoint 4B
|
2.179
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
2.176
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
2.173
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
2.17
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
2.156
|
|
MB
|
myoglobin
|
2.154
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
2.151
|
|
FUS
|
FUS RNA binding protein
|
2.139
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
2.127
|
|
SYP
|
synaptophysin
|
2.103
|
|
EGFR
|
epidermal growth factor receptor
|
2.096
|
|
SSX2B
|
synovial sarcoma, X breakpoint 2B
|
2.094
|
|
CCND1
|
cyclin D1
|
2.079
|
|
TFE3
|
transcription factor binding to IGHM enhancer 3
|
2.077
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
2.076
|
|
PRUNE2
|
prune homolog 2 (Drosophila)
|
2.074
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
2.074
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
2.068
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
2.068
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
2.064
|
|
BRCA1
|
breast cancer 1, early onset
|
2.064
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
2.062
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
2.053
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
2.04
|
|
IGF2
|
insulin-like growth factor 2
|
2.038
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
2.038
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
2.032
|
|
CD8A
|
CD8a molecule
|
2.023
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
2.02
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
2.02
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
2.011
|
|
NCAM1
|
neural cell adhesion molecule 1
|
2.008
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.99
|
|
PHF1
|
PHD finger protein 1
|
1.983
|
|
KRT5
|
keratin 5, type II
|
1.982
|
|
PAX8
|
paired box 8
|
1.978
|
|
BRCA2
|
breast cancer 2, early onset
|
1.978
|
|
KRT20
|
keratin 20, type I
|
1.978
|
|
AFP
|
alpha-fetoprotein
|
1.969
|
|
NTRK3
|
neurotrophic tyrosine kinase, receptor, type 3
|
1.968
|
|
DAXX
|
death-domain associated protein
|
1.966
|
|
KDR
|
kinase insert domain receptor
|
1.941
|
|
CTAG1B
|
cancer/testis antigen 1B
|
1.933
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
1.925
|
|
PAX7
|
paired box 7
|
1.91
|
|
CD163
|
CD163 molecule
|
1.909
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
1.909
|
|
FOXO1
|
forkhead box O1
|
1.894
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
1.88
|
|
TERT
|
telomerase reverse transcriptase
|
1.877
|
|
PDCD1
|
programmed cell death 1
|
1.871
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.868
|
|
MITF
|
microphthalmia-associated transcription factor
|
1.867
|
|
HEATR3
|
HEAT repeat containing 3
|
1.862
|
|
CD47
|
CD47 molecule
|
1.856
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
1.842
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
1.838
|
|
TSC2
|
tuberous sclerosis 2
|
1.836
|
|
MYOCD
|
myocardin
|
1.823
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
1.82
|
|
RAD51B
|
RAD51 paralog B
|
1.819
|
|
CD4
|
CD4 molecule
|
1.819
|
|
RET
|
ret proto-oncogene
|
1.811
|
|
FLT1
|
fms-related tyrosine kinase 1
|
1.807
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
1.805
|
|
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1
|
1.805
|
|
MEAF6
|
MYST/Esa1-associated factor 6
|
1.799
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.784
|
|
SIRPA
|
signal-regulatory protein alpha
|
1.783
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
1.782
|
|
PXDN
|
peroxidasin
|
1.779
|
|
PXDNL
|
peroxidasin-like
|
1.775
|
|
ATM
|
ATM serine/threonine kinase
|
1.775
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
1.746
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
1.744
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
1.74
|
|
MSH2
|
mutS homolog 2
|
1.74
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
1.739
|
|
SATB2
|
SATB homeobox 2
|
1.736
|
|
ROS1
|
ROS proto-oncogene 1 , receptor tyrosine kinase
|
1.732
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.722
|
|
NUTM2B
|
NUT family member 2B
|
1.721
|
|
NT5DC2
|
5'-nucleotidase domain containing 2
|
1.72
|
|
NCOA2
|
nuclear receptor coactivator 2
|
1.714
|
|
CHGA
|
chromogranin A
|
1.711
|
|
EGF
|
epidermal growth factor
|
1.698
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
1.696
|
|
FLT4
|
fms-related tyrosine kinase 4
|
1.695
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
1.691
|
|
PCNA
|
proliferating cell nuclear antigen
|
1.688
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.684
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
1.684
|
|
HDAC9
|
histone deacetylase 9
|
1.683
|
|
MLH1
|
mutL homolog 1
|
1.683
|
|
FN1
|
fibronectin 1
|
1.682
|
|
IFNG
|
interferon, gamma
|
1.679
|
|
SLMAP
|
sarcolemma associated protein
|
1.672
|
|
MSH6
|
mutS homolog 6
|
1.669
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
1.668
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
1.668
|
|
CDK8
|
cyclin-dependent kinase 8
|
1.665
|
|
COL1A1
|
collagen, type I, alpha 1
|
1.663
|
|
CCNB3
|
cyclin B3
|
1.661
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
1.66
|
|
ALB
|
albumin
|
1.658
|
|
KRT8
|
keratin 8, type II
|
1.657
|
|
TPM3
|
tropomyosin 3
|
1.655
|
|
CD44
|
CD44 molecule (Indian blood group)
|
1.65
|
|
CDK6
|
cyclin-dependent kinase 6
|
1.639
|
|
ETV6
|
ets variant 6
|
1.628
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
1.624
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
1.617
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
1.616
|
|
H3-3B
|
H3.3 histone B
|
1.613
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
1.613
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
1.608
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
1.608
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
1.6
|
|
AURKA
|
aurora kinase A
|
1.593
|
|
ACTB
|
actin, beta
|
1.592
|
|
KRT19
|
keratin 19, type I
|
1.59
|
|
MAGEA4
|
melanoma antigen family A4
|
1.588
|
|
IL2
|
interleukin 2
|
1.579
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.572
|
|
H3C12
|
H3 clustered histone 12
|
1.569
|
|
NF2
|
neurofibromin 2 (merlin)
|
1.569
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
1.563
|
|
GAPDH
|
glyceraldehyde-3-phosphate dehydrogenase
|
1.56
|
|
CCNE1
|
cyclin E1
|
1.558
|
|
CHEK2
|
checkpoint kinase 2
|
1.558
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
1.557
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
1.556
|
|
RB1
|
retinoblastoma 1
|
1.552
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
1.551
|
|
CAMTA1
|
calmodulin binding transcription activator 1
|
1.547
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.547
|
|
JUN
|
jun proto-oncogene
|
1.546
|
|
IL6
|
interleukin 6
|
1.546
|
|
SMTN
|
smoothelin
|
1.545
|
|
AXL
|
AXL receptor tyrosine kinase
|
1.543
|
|
GFAP
|
glial fibrillary acidic protein
|
1.543
|
|
TPM4
|
tropomyosin 4
|
1.539
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
1.535
|
|
TNF
|
tumor necrosis factor
|
1.535
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
1.535
|
|
TSPAN31
|
tetraspanin 31
|
1.532
|
|
LAG3
|
lymphocyte-activation gene 3
|
1.531
|
|
H3-4
|
H3.4 histone, cluster member
|
1.531
|
|
GLI1
|
GLI family zinc finger 1
|
1.527
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
1.525
|
|
H3C13
|
H3 clustered histone 13
|
1.525
|
|
TP63
|
tumor protein p63
|
1.522
|
|
H3-5
|
H3.5 histone
|
1.521
|
|
GATA3
|
GATA binding protein 3
|
1.516
|
|
RANBP2
|
RAN binding protein 2
|
1.512
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
1.508
|
|
MMP2
|
matrix metallopeptidase 2
|
1.505
|
|
BRD8
|
bromodomain containing 8
|
1.503
|
|
PDPN
|
podoplanin
|
1.503
|
|
CRP
|
C-reactive protein, pentraxin-related
|
1.503
|
|
CREB3L2
|
cAMP responsive element binding protein 3-like 2
|
1.502
|
|
KITLG
|
KIT ligand
|
1.5
|
|
CDK2
|
cyclin-dependent kinase 2
|
1.5
|
|
BCORL1
|
BCL6 corepressor-like 1
|
1.498
|
|
CLTC
|
clathrin, heavy chain (Hc)
|
1.495
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
1.494
|
|
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
|
1.493
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
1.49
|
|
RAD51
|
RAD51 recombinase
|
1.49
|
|
TAGLN
|
transgelin
|
1.487
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
1.485
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
1.482
|
|
FOXP3
|
forkhead box P3
|
1.48
|
|
RHD
|
Rh blood group, D antigen
|
1.479
|
|
CNN1
|
calponin 1, basic, smooth muscle
|
1.478
|
|
KLK3
|
kallikrein-related peptidase 3
|
1.476
|
|
YAP1
|
Yes-associated protein 1
|
1.475
|
|
MUC4
|
mucin 4, cell surface associated
|
1.472
|
|
CHEK1
|
checkpoint kinase 1
|
1.467
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
1.462
|
|
KRT18
|
keratin 18, type I
|
1.461
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
1.458
|
|
CAPN6
|
calpain 6
|
1.457
|
|
CDX2
|
caudal type homeobox 2
|
1.452
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
1.451
|
|
MUC1
|
mucin 1, cell surface associated
|
1.45
|
|
CCNC
|
cyclin C
|
1.45
|
|
ARL4C
|
ADP-ribosylation factor-like 4C
|
1.447
|
|
JAK2
|
Janus kinase 2
|
1.445
|
|
JAK1
|
Janus kinase 1
|
1.445
|
|
COL4A6
|
collagen, type IV, alpha 6
|
1.444
|
|
TAGLN3
|
transgelin 3
|
1.443
|
|
TCHP
|
trichoplein, keratin filament binding
|
1.438
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
1.436
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
1.434
|
|
AR
|
androgen receptor
|
1.434
|
|
SNAI2
|
snail family zinc finger 2
|
1.432
|
|
LMOD1
|
leiomodin 1 (smooth muscle)
|
1.431
|
|
NKX2-1
|
NK2 homeobox 1
|
1.43
|
|
CTSK
|
cathepsin K
|
1.429
|
|
INS
|
insulin
|
1.422
|
|
THBS1
|
thrombospondin 1
|
1.422
|
|
VIM
|
vimentin
|
1.419
|
|
CA9
|
carbonic anhydrase IX
|
1.415
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
1.414
|
|
SNAI1
|
snail family zinc finger 1
|
1.411
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
1.41
|
|
VGLL3
|
vestigial-like family member 3
|
1.408
|
|
DES
|
desmin
|
1.402
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
1.399
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
1.397
|
|
FLT3
|
fms-related tyrosine kinase 3
|
1.396
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
1.396
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
1.395
|
|
IL10
|
interleukin 10
|
1.395
|
|
DICER1
|
dicer 1, ribonuclease type III
|
1.388
|
|
DUX4
|
double homeobox 4
|
1.385
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
1.382
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
1.382
|
|
CD248
|
CD248 molecule, endosialin
|
1.381
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.381
|
|
MCAM
|
melanoma cell adhesion molecule
|
1.381
|
|
CCND2
|
cyclin D2
|
1.38
|
|
NOTCH1
|
notch 1
|
1.38
|
|
PGM1
|
phosphoglucomutase 1
|
1.379
|
|
ITGA7
|
integrin, alpha 7
|
1.378
|
|
MMP9
|
matrix metallopeptidase 9
|
1.378
|
|
TYR
|
tyrosinase
|
1.376
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
1.375
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
1.375
|
|
PROM1
|
prominin 1
|
1.373
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
1.371
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
1.37
|
|
SLITRK4
|
SLIT and NTRK-like family, member 4
|
1.368
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.365
|
|
BAX
|
BCL2-associated X protein
|
1.361
|
|
ATF1
|
activating transcription factor 1
|
1.358
|
|
MBTD1
|
mbt domain containing 1
|
1.356
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
1.356
|
|
POU5F1
|
POU class 5 homeobox 1
|
1.355
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
1.355
|
|
ETV1
|
ets variant 1
|
1.353
|
|
MAGEA3
|
melanoma antigen family A3
|
1.351
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
1.351
|
|
YEATS4
|
YEATS domain containing 4
|
1.35
|
|
STK11
|
serine/threonine kinase 11
|
1.35
|
|
NT5DC4
|
5'-nucleotidase domain containing 4
|
1.348
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
1.348
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
1.348
|
|
BCL2L1
|
BCL2-like 1
|
1.348
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
1.347
|
|
MYLK
|
myosin light chain kinase
|
1.34
|
|
CCNL2
|
cyclin L2
|
1.338
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
1.337
|
|
GID4
|
GID complex subunit 4
|
1.337
|
|
VGLL2
|
vestigial-like family member 2
|
1.337
|
|
FLCN
|
folliculin
|
1.337
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
1.332
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
1.331
|
|
CDK1
|
cyclin-dependent kinase 1
|
1.331
|
|
PBRM1
|
polybromo 1
|
1.331
|
|
HDAC4
|
histone deacetylase 4
|
1.33
|
|
CCNB1
|
cyclin B1
|
1.329
|
|
TAGLN2
|
transgelin 2
|
1.324
|
|
NANOG
|
Nanog homeobox
|
1.323
|
|
E2F1
|
E2F transcription factor 1
|
1.323
|
|
SDHC
|
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa
|
1.323
|
|
CD19
|
CD19 molecule
|
1.322
|
|
CD1E
|
CD1e molecule
|
1.321
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.321
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
1.32
|
|
CD1A
|
CD1a molecule
|
1.319
|
|
ANXA5
|
annexin A5
|
1.317
|
|
AURKB
|
aurora kinase B
|
1.314
|
|
RAD51D
|
RAD51 paralog D
|
1.313
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.313
|
|
KCNIP4
|
Kv channel interacting protein 4
|
1.312
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
1.311
|
|
COL4A5
|
collagen, type IV, alpha 5
|
1.311
|
|
FSCN1
|
fascin actin-bundling protein 1
|
1.31
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
1.308
|
|
ASS1
|
argininosuccinate synthase 1
|
1.306
|
|
CD1B
|
CD1b molecule
|
1.303
|
|
NES
|
nestin
|
1.3
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
1.3
|
|
FOXM1
|
forkhead box M1
|
1.296
|
|
MEF2D
|
myocyte enhancer factor 2D
|
1.295
|
|
SHH
|
sonic hedgehog
|
1.295
|
|
PRKCQ
|
protein kinase C, theta
|
1.29
|
|
EPCAM
|
epithelial cell adhesion molecule
|
1.288
|
|
CD86
|
CD86 molecule
|
1.286
|
|
PTCH1
|
patched 1
|
1.286
|
|
KANSL1
|
KAT8 regulatory NSL complex subunit 1
|
1.286
|
|
TIGIT
|
T cell immunoreceptor with Ig and ITIM domains
|
1.286
|
|
CREB3L1
|
cAMP responsive element binding protein 3-like 1
|
1.284
|
|
CD1C
|
CD1c molecule
|
1.283
|
|
RAD51C
|
RAD51 paralog C
|
1.283
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
1.281
|
|
PLK1
|
polo-like kinase 1
|
1.28
|
|
CD1D
|
CD1d molecule
|
1.276
|
|
CD80
|
CD80 molecule
|
1.274
|
|
MYF5
|
myogenic factor 5
|
1.272
|
|
FGF3
|
fibroblast growth factor 3
|
1.272
|
|
MEN1
|
multiple endocrine neoplasia I
|
1.271
|
|
MAML3
|
mastermind-like 3 (Drosophila)
|
1.27
|
|
FGF7
|
fibroblast growth factor 7
|
1.27
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
1.269
|
|
KAT6B
|
K(lysine) acetyltransferase 6B
|
1.269
|
|
FGF4
|
fibroblast growth factor 4
|
1.268
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
1.267
|
|
ERCC5
|
excision repair cross-complementation group 5
|
1.266
|
|
COL6A3
|
collagen, type VI, alpha 3
|
1.265
|
|
ENG
|
endoglin
|
1.265
|
|
USP6
|
ubiquitin specific peptidase 6
|
1.264
|
|
FGF10
|
fibroblast growth factor 10
|
1.264
|
|
NKX2-2
|
NK2 homeobox 2
|
1.261
|
|
EZHIP
|
EZH inhibitory protein
|
1.261
|
|
ETV4
|
ets variant 4
|
1.26
|
|
TYRO3
|
TYRO3 protein tyrosine kinase
|
1.258
|
|
GPC3
|
glypican 3
|
1.257
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
1.255
|
|
EP300
|
E1A binding protein p300
|
1.254
|
|
MYF6
|
myogenic factor 6 (herculin)
|
1.252
|
|
MSR1
|
macrophage scavenger receptor 1
|
1.251
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
1.25
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
1.249
|
|
CCNA2
|
cyclin A2
|
1.249
|
|
SMAD4
|
SMAD family member 4
|
1.248
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
1.247
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
1.246
|
|
FGF18
|
fibroblast growth factor 18
|
1.246
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
1.243
|
|
IFNA1
|
interferon, alpha 1
|
1.243
|
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
1.243
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
1.242
|
|
TSPAN7
|
tetraspanin 7
|
1.241
|
|
TNS1
|
tensin 1
|
1.24
|
|
SSX3
|
synovial sarcoma, X breakpoint 3
|
1.239
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
1.239
|
|
IRF1
|
interferon regulatory factor 1
|
1.238
|
|
COMMD3-BMI1
|
COMMD3-BMI1 readthrough
|
1.238
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
1.237
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
1.233
|
|
PALB2
|
partner and localizer of BRCA2
|
1.231
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
1.231
|
|
CD276
|
CD276 molecule
|
1.229
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
1.227
|
|
ALPP
|
alkaline phosphatase, placental
|
1.225
|
|
BIVM-ERCC5
|
BIVM-ERCC5 readthrough
|
1.225
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
1.223
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
1.221
|
|
B2M
|
beta-2-microglobulin
|
1.219
|
|
EPAS1
|
endothelial PAS domain protein 1
|
1.219
|
|
CHCHD7
|
coiled-coil-helix-coiled-coil-helix domain containing 7
|
1.219
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
1.216
|
|
NOTCH2
|
notch 2
|
1.216
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
1.211
|
|
CCND3
|
cyclin D3
|
1.208
|
|
TSPAN10
|
tetraspanin 10
|
1.207
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
1.206
|
|
FGF6
|
fibroblast growth factor 6
|
1.205
|
|
FGF16
|
fibroblast growth factor 16
|
1.205
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
1.203
|
|
RECQL4
|
RecQ protein-like 4
|
1.202
|
|
FGF17
|
fibroblast growth factor 17
|
1.201
|
|
LMNA
|
lamin A/C
|
1.199
|
|
TGFA
|
transforming growth factor, alpha
|
1.198
|
|
NGFR
|
nerve growth factor receptor
|
1.198
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
1.198
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
1.197
|
|
SST
|
somatostatin
|
1.196
|
|
NAV2
|
neuron navigator 2
|
1.196
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
1.196
|
|
FGF20
|
fibroblast growth factor 20
|
1.196
|
|
PTK2
|
protein tyrosine kinase 2
|
1.195
|
|
TDO2
|
tryptophan 2,3-dioxygenase
|
1.194
|
|
FOXL2
|
forkhead box L2
|
1.193
|
|
FGF22
|
fibroblast growth factor 22
|
1.193
|
|
CTAG2
|
cancer/testis antigen 2
|
1.192
|
|
SETD2
|
SET domain containing 2
|
1.191
|
|
FGF5
|
fibroblast growth factor 5
|
1.19
|
|
BRD4
|
bromodomain containing 4
|
1.189
|
|
HDAC1
|
histone deacetylase 1
|
1.189
|
|
IL1B
|
interleukin 1, beta
|
1.188
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
1.187
|
|
CD28
|
CD28 molecule
|
1.185
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
1.184
|
|
SDC1
|
syndecan 1
|
1.183
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
1.182
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
1.181
|
|
BET1L
|
Bet1 golgi vesicular membrane trafficking protein-like
|
1.181
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
1.181
|
|
FGF9
|
fibroblast growth factor 9
|
1.181
|
|
MDM4
|
MDM4, p53 regulator
|
1.18
|
|
NAPSA
|
napsin A aspartic peptidase
|
1.179
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
1.178
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
1.176
|
|
XPO1
|
exportin 1
|
1.176
|
|
CYCS
|
cytochrome c, somatic
|
1.175
|
|
SALL4
|
spalt-like transcription factor 4
|
1.172
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
1.172
|
|
RORB
|
RAR-related orphan receptor B
|
1.172
|
|
CREB1
|
cAMP responsive element binding protein 1
|
1.168
|
|
ASAH2
|
N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2
|
1.168
|
|
GTSE1
|
G-2 and S-phase expressed 1
|
1.167
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
1.165
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
1.164
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
1.163
|
|
STMN1
|
stathmin 1
|
1.162
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
1.159
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.157
|
|
FBLIM1
|
filamin binding LIM protein 1
|
1.156
|
|
PAX5
|
paired box 5
|
1.156
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
1.154
|
|
FANCA
|
Fanconi anemia, complementation group A
|
1.153
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
1.152
|
|
ARG1
|
arginase 1
|
1.152
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
1.151
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
1.151
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.15
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
1.15
|
|
INSM1
|
insulinoma-associated 1
|
1.149
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
1.149
|
|
NT5DC1
|
5'-nucleotidase domain containing 1
|
1.148
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
1.147
|
|
SPP1
|
secreted phosphoprotein 1
|
1.147
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
1.144
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
1.144
|
|
RRBP1
|
ribosome binding protein 1
|
1.143
|
|
VWF
|
von Willebrand factor
|
1.141
|
|
MCL1
|
myeloid cell leukemia 1
|
1.141
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
1.139
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
1.139
|
|
EXT1
|
exostosin glycosyltransferase 1
|
1.129
|
|
PPP2R1A
|
protein phosphatase 2, regulatory subunit A, alpha
|
1.126
|
|
STAG2
|
stromal antigen 2
|
1.126
|
|
USP18
|
ubiquitin specific peptidase 18
|
1.125
|
|
RCBTB1
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1
|
1.125
|
|
MEF2A
|
myocyte enhancer factor 2A
|
1.123
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
1.122
|
|
LDHD
|
lactate dehydrogenase D
|
1.12
|
|
IL4
|
interleukin 4
|
1.118
|
|
CALML3
|
calmodulin-like 3
|
1.115
|
|
PPP1R36
|
protein phosphatase 1, regulatory subunit 36
|
1.115
|
|
MRC1
|
mannose receptor, C type 1
|
1.114
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
1.114
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.113
|
|
CDK12
|
cyclin-dependent kinase 12
|
1.11
|
|
CALML4
|
calmodulin-like 4
|
1.108
|
|
MED13
|
mediator complex subunit 13
|
1.108
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
1.108
|
|
CALML6
|
calmodulin-like 6
|
1.108
|
|
ERCC1
|
excision repair cross-complementation group 1
|
1.105
|
|
CALML5
|
calmodulin-like 5
|
1.105
|
|
HOOK2
|
hook microtubule-tethering protein 2
|
1.105
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
1.103
|
|
FGF13
|
fibroblast growth factor 13
|
1.103
|
|
NCOA1
|
nuclear receptor coactivator 1
|
1.103
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
1.101
|
|
PSME1
|
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha)
|
1.097
|
|
CDC42
|
cell division cycle 42
|
1.097
|
|
NCOR1
|
nuclear receptor corepressor 1
|
1.095
|
|
ERCC2
|
excision repair cross-complementation group 2
|
1.094
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
1.094
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
1.093
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
1.093
|
|
CREBBP
|
CREB binding protein
|
1.092
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
1.089
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
1.088
|
|
NT5DC3
|
5'-nucleotidase domain containing 3
|
1.087
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
1.087
|
|
TFCP2
|
transcription factor CP2
|
1.086
|
|
BARD1
|
BRCA1 associated RING domain 1
|
1.084
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.084
|
|
SLC35E3
|
solute carrier family 35, member E3
|
1.083
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
1.083
|
|
HDAC8
|
histone deacetylase 8
|
1.08
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.08
|
|
ZNF444
|
zinc finger protein 444
|
1.079
|
|
RNF223
|
ring finger protein 223
|
1.079
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
1.078
|
|
PDLIM7
|
PDZ and LIM domain 7 (enigma)
|
1.078
|
|
VEGFC
|
vascular endothelial growth factor C
|
1.078
|
|
NOTCH3
|
notch 3
|
1.076
|
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
1.073
|
|
IRS1
|
insulin receptor substrate 1
|
1.071
|
|
CD70
|
CD70 molecule
|
1.068
|
|
PLAU
|
plasminogen activator, urokinase
|
1.068
|
|
CDK19
|
cyclin-dependent kinase 19
|
1.068
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
1.068
|
|
CD5
|
CD5 molecule
|
1.067
|
|
H2AX
|
H2A.X variant histone
|
1.066
|
|
BRD9
|
bromodomain containing 9
|
1.065
|
|
THY1
|
Thy-1 cell surface antigen
|
1.063
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.061
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
1.059
|
|
CCN2
|
cellular communication network factor 2
|
1.059
|
|
POTEF
|
POTE ankyrin domain family, member F
|
1.058
|
|
PLCG1
|
phospholipase C, gamma 1
|
1.057
|
|
TG
|
thyroglobulin
|
1.056
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
1.055
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
1.055
|
|
HMGA1
|
high mobility group AT-hook 1
|
1.055
|
|
GAST
|
gastrin
|
1.052
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
1.051
|
|
EXT2
|
exostosin glycosyltransferase 2
|
1.05
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
1.05
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.049
|
|
CD24
|
CD24 molecule
|
1.049
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
1.047
|
|
C3ORF62
|
chromosome 3 open reading frame 62
|
1.045
|
|
PMEL
|
premelanosome protein
|
1.044
|
|
GAS6
|
growth arrest-specific 6
|
1.043
|
|
LDHA
|
lactate dehydrogenase A
|
1.041
|
|
INSR
|
insulin receptor
|
1.041
|
|
PSMB8
|
proteasome (prosome, macropain) subunit, beta type, 8
|
1.04
|
|
BANF1
|
barrier to autointegration factor 1
|
1.038
|
|
KRT14
|
keratin 14, type I
|
1.038
|
|
GINS2
|
GINS complex subunit 2 (Psf2 homolog)
|
1.036
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
1.034
|
|
DNTT
|
DNA nucleotidylexotransferase
|
1.034
|
|
EGR1
|
early growth response 1
|
1.033
|
|
MSLN
|
mesothelin
|
1.032
|
|
OSCAR
|
osteoclast associated, immunoglobulin-like receptor
|
1.031
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
1.03
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
1.029
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
1.028
|
|
PXN
|
paxillin
|
1.028
|
|
PRSS38
|
protease, serine, 38
|
1.026
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
1.024
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
1.024
|
|
RHOA
|
ras homolog family member A
|
1.023
|
|
RBL2
|
retinoblastoma-like 2
|
1.02
|
|
AXIN1
|
axin 1
|
1.019
|
|
PAX2
|
paired box 2
|
1.019
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
1.018
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
1.017
|
|
MUC16
|
mucin 16, cell surface associated
|
1.017
|
|
LRRC15
|
leucine rich repeat containing 15
|
1.017
|
|
TSC1
|
tuberous sclerosis 1
|
1.016
|
|
KAT2A
|
K(lysine) acetyltransferase 2A
|
1.016
|
|
VSIR
|
V-set immunoregulatory receptor
|
1.015
|
|
PLIN2
|
perilipin 2
|
1.014
|
|
RBP1
|
retinol binding protein 1, cellular
|
1.014
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
1.014
|
|
MELK
|
maternal embryonic leucine zipper kinase
|
1.014
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
1.013
|
|
RUNX2
|
runt-related transcription factor 2
|
1.013
|
|
PRF1
|
perforin 1 (pore forming protein)
|
1.012
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
1.012
|
|
CCNA1
|
cyclin A1
|
1.011
|
|
IDO2
|
indoleamine 2,3-dioxygenase 2
|
1.01
|
|
C11ORF68
|
chromosome 11 open reading frame 68
|
1.009
|
|
BNIP2
|
BCL2/adenovirus E1B 19kDa interacting protein 2
|
1.009
|
|
CKM
|
creatine kinase, muscle
|
1.009
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.008
|
|
CCK
|
cholecystokinin
|
1.007
|
|
COPS3
|
COP9 signalosome subunit 3
|
1.007
|
|
GNAS
|
GNAS complex locus
|
1.007
|
|
JAG1
|
jagged 1
|
1.007
|
|
MEF2B
|
myocyte enhancer factor 2B
|
1.004
|
|
MFAP5
|
microfibrillar associated protein 5
|
1.002
|
|
RCN3
|
reticulocalbin 3, EF-hand calcium binding domain
|
1.002
|
